galactosamine has been researched along with nootkatone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, B; Jia, Y; Li, F; Wu, B; Xiao, F; Xiong, W; Yan, T | 1 |
1 other study(ies) available for galactosamine and nootkatone
| Article | Year |
|---|---|
Nootkatone improves anxiety- and depression-like behavior by targeting hyperammonemia-induced oxidative stress in D-galactosamine model of liver injury.
Topics: Ammonia; Animals; Antidepressive Agents; Antioxidants; Anxiety; Behavior, Animal; Brain; Cell Survival; Chemical and Drug Induced Liver Injury; Depression; Galactosamine; Hyperammonemia; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; PC12 Cells; Polycyclic Sesquiterpenes; Rats | 2021 |